FAQ

pediatric acute myeloblastic leukemia

Known as: AML, childhood, pediatric AGL, AGL, pediatric 
Acute myeloid leukemia occurring in childhood.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1936-2017
050019362016

Related topics

Related topics

19 relations
AIE RegimenBone MarrowBone marrow stem cellCytarabine-Daunorubicin Regimen
(More)

Narrower (1)

childhood acute myeloblastic leukemia without maturation (M1)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
pediatric acute myeloblastic leukemia
cancer cell
Bone Marrow
Neoplastic Cell
Leukemic Cell
DAV regimen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Oral apixaban for the treatment of acute venous thromboembolism.
BACKGROUND Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Transfusion strategies for acute upper gastrointestinal bleeding.
BACKGROUND The hemoglobin threshold for transfusion of red cells in patients with acute gastrointestinal bleeding is… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Oral rivaroxaban for symptomatic venous thromboembolism.
BACKGROUND Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Effect of dutasteride on the risk of prostate cancer.
BACKGROUND We conducted a study to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3…
PURPOSE To analyze the frequency and prognostic impact of isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia.
Pediatric de novo acute myeloid leukemia (AML) is an aggressive malignancy with current therapy resulting in cure rates of only… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
Acute myeloid leukemia (AML) carrying NPM1 mutations and cytoplasmic nucleophosmin (NPMc+ AML) accounts for about one-third of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
IAP Guidelines for the Surgical Management of Acute Pancreatitis.
During 2002 the International Association of Pancreatology developed evidenced-based guidelines on the surgical management of… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
BACKGROUND Ear infections are a common cause of illness during the first two years of life. New conjugate vaccines may be able to… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Risk assessment after acute upper gastrointestinal haemorrhage.
The aim of this study was to establish the relative importance of risk factors for mortality after acute upper gastrointestinal… (More)
  • table I
  • table II
  • table IV
  • table IV
  • figure 2
Is this relevant?